Need a specific person's email?
Browse Zai Lab's employee directory (about 536 employees) and reveal verified emails free.
Zai Lab's most common email format is First.Last@zailaboratory.com (ex. John.Doe@zailaboratory.com), used for 89% of zailaboratory.com addresses. Zai Lab uses 4 email patterns.
| Format | Example | Share of zailaboratory.com |
|---|---|---|
| First.Last@zailaboratory.comMost common | John.Doe@zailaboratory.com | |
| FLast@zailaboratory.com | JDoe@zailaboratory.com | |
| First.Middle@zailaboratory.com | John.Michael@zailaboratory.com | |
| FirstMiddle.Last@zailaboratory.com | JohnMichael.Doe@zailaboratory.com |
Browse Zai Lab's employee directory (about 536 employees) and reveal verified emails free.
Biotechnology ResearchShanghai, China501-1000 Employees
Zai Lab is a mid-sized biopharmaceutical company with operations in China and the United States, anchored by a presence in Shanghai. It conducts biotechnology research and focuses on discovering, developing, and commercializing therapies for conditions with significant unmet patient needs across oncology, autoimmune disorders, infectious diseases and neurological disorders. The firm aims to broaden patient access and health impact, targeting to reach one million patients by 2030, and operates at a commercial stage with activities spanning global markets. In recent developments, it has engaged in collaboration with Boehringer Ingelheim to evaluate a combination therapy that pairs Boehringer Ingelheim's DLL3/CD3 T-cell engager with Zai Lab's antibody-drug conjugate in a Phase Ib/II study, reflecting an emphasis on combination approaches. The organization is described as having a cross-border footprint, with headquarters in Shanghai and operations in the United States, and it is characterized as a mid-sized biotechnology company.
Most common format
First.Last@zailaboratory.com
Example: John.Doe@zailaboratory.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.